Compare, Analyse with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   MYLAN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
MYLAN
Dec-18
ALKEM LABORATORIES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,5893,422-   
Low Rs1,2321,884-   
Sales per share (Unadj.) Rs417.51,574.6-  
Earnings per share (Unadj.) Rs56.342.8-  
Cash flow per share (Unadj.) Rs64.7337.6-  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.91,703.4-  
Shares outstanding (eoy) m119.57514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.7 200.6%   
Avg P/E ratio x25.162.0 40.4%  
P/CF ratio (eoy) x21.87.9 277.4%  
Price / Book Value ratio x4.81.6 309.2%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6531,364,835 12.4%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m9,1710-   
Avg. sales/employee Rs ThNM23,146.5-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM628.5-  
INCOME DATA
Net Sales Rs m49,915810,128 6.2%  
Other income Rs m1,6450-   
Total revenues Rs m51,561810,128 6.4%   
Gross profit Rs m8,482209,631 4.0%  
Depreciation Rs m1,006151,688 0.7%   
Interest Rs m67138,964 1.7%   
Profit before tax Rs m8,45118,979 44.5%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606-3,019 -53.2%   
Profit after tax Rs m6,73121,998 30.6%  
Gross profit margin %17.025.9 65.7%  
Effective tax rate %19.0-15.9 -119.5%   
Net profit margin %13.52.7 496.6%  
BALANCE SHEET DATA
Current assets Rs m27,062452,375 6.0%   
Current liabilities Rs m15,324329,831 4.6%   
Net working cap to sales %23.515.1 155.5%  
Current ratio x1.81.4 128.8%  
Inventory Days Days6784 79.6%  
Debtors Days Days4193 44.2%  
Net fixed assets Rs m12,610157,152 8.0%   
Share capital Rs m239431 55.4%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,027876,411 4.0%   
Long term debt Rs m1,212945,929 0.1%   
Total assets Rs m54,3872,350,875 2.3%  
Interest coverage x13.61.5 914.7%   
Debt to equity ratio x01.1 3.2%  
Sales to assets ratio x0.90.3 266.3%   
Return on assets %13.62.6 524.8%  
Return on equity %19.22.5 765.6%  
Return on capital %24.93.2 781.8%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,259168,345 4.3%  
From Investments Rs m1,864-87,016 -2.1%  
From Financial Activity Rs m-9,273-78,425 11.8%  
Net Cashflow Rs m-1501,395 -10.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare ALKEM LABORATORIES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: NATCO PHARMA  GSK PHARMA  DISHMAN PHARMA  ABBOTT INDIA  DR. REDDYS LAB  



Today's Market

Sensex Opens in Green; FMCG and Metal Stocks Gain(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 2% while the Hang Seng is down 0.3%.

Related Views On News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks (Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

Here's Why I Recommended 15 Stocks in One Day Flat Views On News (Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

The Top 8 Trading Mistakes You Should Avoid (Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

These Rebirth of India Stocks Are Raring to Compete with Tesla (The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

Corona Virus Could Trigger a Rally in this Stock (Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
LIVE NOW!: Equitymaster's Biggest Wealth Creating Project Ever is LIVE. Watch Now!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

ALKEM LABORATORIES SHARE PRICE


Feb 25, 2020 11:59 AM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

OTHER USEFUL LINKS

MARKET STATS